NEW YORK (GenomeWeb News) – Invitrogen has signed a non-binding letter of intent to collaborate with the International Regulome Consortium on the development of stem cell research tools, the firms announced yesterday at the Biotechnology Industry Organization annual meeting in San Diego.
Under terms of the pact, Invitrogen will contribute unspecified services and technologies to help IRC researchers map the “genetic circuit board” that regulates how stem cells give rise to specialized cells, such as neurons.